🔗 Share this article Social Media Influencers Fueling Unofficial Market for Unapproved Weight-Loss Drug An underground economy for unapproved weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations. Investigational Treatment Gaining Popularity Online The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also receiving promotional offers. Active Trade on Messaging Platforms Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for transactions. Understanding The Experimental Drug This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic. Healthcare Professionals Express Worries Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in users injecting products of uncertain source. Some experts stated the demand for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro. Legal Position and Enforcement Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations. Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, risking penalties, legal action or prison. Platform Reaction and Material Removal Based on TikTok, the platform has taken down problematic material and banned associated keywords and query recommendations. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening enforcement strategies. Online Marketplace Operations Investigations also discovered communities with up to nine thousand participants marketing retatrutide using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, glowing reviews and detailed guides for mixing or injecting at residence. Within minutes of joining one group, a seller shared contact information, where most transactions occur. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience. Product Information and Pricing Inside these groups, messages show dark colored packages with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.” Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When questioned how long a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”. Service Oversight and Security Actions A spokesperson for the messaging service said it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”. Healthcare Expert Cautions “Individuals are injecting substances they can’t verify. Even if the research behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U. Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the environment they were produced in was clean,” she said. Her staff has already seen patients injured by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.” Manufacturer Statement A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.